Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis [Phase 4]
Phase 4 trial comparing the Epiceram device with Fluticasone Propionate 0.05% for Atopic Dermatitis has completed. The study was sponsored b…
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis [Phase 4]
This document reports results from a Phase 4 trial evaluating quality of life and safety of 1% pimecrolimus cream in pediatric atopic dermat…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis [Phase 4]
This Phase 4 clinical trial compares Epiceram with Elidel for treating mild to moderate atopic dermatitis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis [Phase 3]
Phase 3 trial update evaluating whether pimecrolimus can reduce the need for topical steroids in pediatric patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Quality of Life Study in Adults With Facial Eczema [Phase 4]
Phase 4 clinical trial evaluating quality of life in adults with facial eczema (atopic dermatitis) sponsored by Novartis. The study has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis [Phase 4]
Phase 4 trial evaluating the efficacy and safety of 1% pimecrolimus cream in children aged 2 to 11 with mild-to-moderate facial atopic derma…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients [Phase 4]
Phase 4 trial assessing the safety and efficacy of pimecrolimus cream 1% in mild-to-moderate head and neck atopic dermatitis patients.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial assessing the safety and efficacy of pimecrolimus cream 1% plus a topical corticosteroid in children aged 2-17 with…
-
FDA approval · 2007-12-27FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for cyclosporine from Apotex Corp. This action approves additional labeling or supply under the supp…
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis [Phase 3]
Extension study results for pediatric patients with atopic dermatitis treated with pimecrolimus cream in Phase 3 have completed.
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis [Phase 4]
A Phase 4 clinical trial evaluated how 1% pimecrolimus cream alters molecular and cellular profiles in adult men with atopic dermatitis.
-
CLINICAL_TRIALS research · 2007-12-17Clinical Trial Update: Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis [Phase 3]
An extension study in adults with atopic dermatitis to assess the safety and efficacy of pimecrolimus in a Phase 3 trial, sponsored by Novar…
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals
This clinical trial update compares cytokine production patterns in patients with systemic mastocytosis to those in individuals with atopic …
-
FDA label_change · 2007-12-12FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis [Phase 2]
Phase 2 open-label trial of Alefacept in patients with Atopic Dermatitis has completed.
-
FDA approval · 2007-11-28FDA Approved: HYDROCORTISONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Hydrocortisone by Padagis Israel Pharmaceuticals Ltd, indicating an update to the product's appr…
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Montelukast as a Controller of Atopic Syndrome [Phase 4]
Phase 4 clinical trial evaluating montelukast for control of atopic syndrome has completed, studying its effects in seasonal allergic rhinit…
-
FDA approval · 2007-09-14FDA Approved: PIMECROLIMUS — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for pimecrolimus from Oceanside Pharmaceuticals, resulting in a modification to the drug's labeling.
-
FDA approval · 2007-09-12FDA Approved: FLUTICASONE PROPIONATE — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for Fluticasone Propionate, submitted by Golden State Medical Supply, Inc.
-
FDA approval · 2007-08-01FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for NEORAL (cyclosporine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands [NA]
A prospective, randomized, double-blind trial comparing two creams in patients with xerosis and Atopic Dermatitis, sponsored by L'Oreal; the…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved the original application for Betamethasone Dipropionate (a generic topical corticosteroid) from E. Fougera & Co., marking appro…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic topical corticosteroid, Betamethasone Dipropionate, under Sun Pharmaceutical Industries' Original Application.
-
CLINICAL_TRIALS research · 2007-04-25Clinical Trial Update: Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis [NA]
This document provides an update on a clinical trial evaluating topical vitamin B12 for childhood atopic dermatitis. The trial status is unk…
-
FDA approval · 2007-04-24FDA Approved: HALOBETASOL PROPIONATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original application for halobetasol propionate, a potent topical corticosteroid used to treat inflamm…